LYKOS THERAPEUTICS lobbying for LYKOS THERAPEUTICS

Filing 2nd Quarter - Termination

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $90,000.00 expenses · posted Jul 21, 2025

Bills named in this filing 3

HR 3944
Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
HR 2483
SUPPORT for Patients and Communities Reauthorization Act of 2025
S 2121
SUPPORT for Patients and Communities Reauthorization Act of 2025

Lobbying activity 4

Budget/Appropriations

Issues related to MDMA Assisted Therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill); issues related to therapeutics and implementation research and development (Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, H.R. 3944 / no Senate bill number).

Defense

Issues related to MDMA Assisted Therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill); issues related to therapeutics and implementation research and development (Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, H.R. 3944 / no Senate bill number).

Health Issues

Issues related to pharmaceutical distribution (SUPPORT for Patients and Communities Reauthorization Act of 2025, H.R. 2483 / S. 2121).

Veterans

Issues related to MDMA Assisted Therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill); issues related to therapeutics and implementation research and development (Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, H.R. 3944 / no Senate bill number).